BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8589011)

  • 1. Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients.
    Chang J; Sharpe JC; A'Hern RP; Fisher C; Blake P; Shepherd J; Gore ME
    Ann Oncol; 1995 Oct; 6(8):755-8. PubMed ID: 8589011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
    Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
    Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases.
    Ariyoshi K; Kawauchi S; Kaku T; Nakano H; Tsuneyoshi M
    Histopathology; 2000 Nov; 37(5):427-36. PubMed ID: 11119124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy.
    Athavale R; Thomakos N; Godfrey K; Kew F; Cross P; de Barros Lopes A; Hatem MH; Naik R
    Int J Gynecol Cancer; 2007; 17(5):1025-30. PubMed ID: 17466043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinosarcomas in female genital tracts: general review].
    Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
    Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based series of ovarian carcinosarcomas with long-term follow-up.
    Paulsson G; Andersson S; Sorbe B
    Anticancer Res; 2013 Mar; 33(3):1003-8. PubMed ID: 23482773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinosarcoma of the ovary a review.
    Cantrell LA; Van Le L
    Obstet Gynecol Surv; 2009 Oct; 64(10):673-80; quiz 697. PubMed ID: 19772676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
    Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
    Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and prognosis of 25 cases of breast carcinosarcoma].
    Yang YF; Liu J; Fang ZY; Gu L
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):620-3. PubMed ID: 23158999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinosarcoma of the ovary.
    Silasi DA; Illuzzi JL; Kelly MG; Rutherford TJ; Mor G; Azodi M; Schwartz PE
    Int J Gynecol Cancer; 2008; 18(1):22-9. PubMed ID: 17451459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinosarcoma of the uterus in advanced stage: a case report.
    Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
    Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary ovarian carcinosarcoma. Report of eight cases].
    Montalvo-Esquivel G; Chanona-Vilchis JG; Herrera-Gómez A; Meneses-García AA; Isla-Ortiz D
    Ginecol Obstet Mex; 2014 Jul; 82(7):483-9. PubMed ID: 25102674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
    Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
    Cicin İ; Özatlı T; Türkmen E; Özturk T; Özçelik M; Çabuk D; Gökdurnalı A; Balvan Ö; Yıldız Y; Şeker M; Özdemir N; Yapar B; Tanrıverdi Ö; Günaydin Y; Menekşe S; Öksüzoğlu B; Aksoy A; Erdogan B; Bekir Hacıoglu M; Arpaci E; Sevinç A
    Balkan Med J; 2016 Sep; 33(5):517-524. PubMed ID: 27761279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas.
    Terada KY; Johnson TL; Hopkins M; Roberts JA
    Gynecol Oncol; 1989 Feb; 32(2):228-32. PubMed ID: 2535999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.